LMR Partners LLP

Position in MRNA — Moderna, Inc.

CIK 1578621 LONDON, X0

Back to MRNA Full portfolio

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,415,740

+$4,380,231 QoQ

Shares Held

63,055

+8920.7% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#164

of 777 holders

Holding Since

Sep 2020

19 quarters on record

Voting authority Sole 28% Shared 72% None 0%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Jun 30, 2026

CallValue

$30,813,200

CallShares

440,000

PutValue

$136,117,311

PutShares

1,943,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. MRNA ranks #12 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	134,214	$40,402,439
2	DNTH	Dianthus Therapeutics, Inc. /DE/	223,995	$21,835,032
3	REGN	Regeneron Pharmaceuticals, Inc.	22,306	$13,908,683
4	TNGX	Tango Therapeutics, Inc.	347,106	$10,850,533
5	RVMD	Revolution Medicines, Inc.	5,112,098	$8,521,240
6	ARGX	Argenx SE	8,200	$7,607,714
7	DFTX	Definium Therapeutics, Inc.	150,200	$7,065,408
8	NKTR	Nektar Therapeutics	100,000	$6,981,000

All Filings in MRNA

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,813,200	440,000	+51.7%	Call	Sole	2026-08-14
2026-06-30	$4,415,740	63,055	+8920.7%	Shares	Sole	2026-08-14
2026-06-30	$136,117,311	1,943,700	+130.4%	Put	Sole	2026-08-14
2026-03-31	$42,859,960	843,700	+20.6%	Put	Sole	2026-05-15
2026-03-31	$35,509	699	-99.3%	Shares	Sole	2026-05-15
2026-03-31	$14,732,000	290,000	+37.7%	Call	Sole	2026-05-15
2025-12-31	$20,622,357	699,300	+18.4%	Put	Sole	2026-02-17
2025-12-31	$3,060,088	103,767	+216.3%	Shares	Sole	2026-02-17
2025-12-31	$6,210,594	210,600	-51.1%	Call	Sole	2026-02-17
2025-09-30	$847,456	32,809	-37.8%	Shares	Sole	2025-11-14
2025-09-30	$15,255,198	590,600	+1049.0%	Put	Sole	2025-11-14
2025-09-30	$11,122,398	430,600	+761.2%	Call	Sole	2025-11-14
2025-06-30	$1,379,500	50,000	-44.6%	Call	Sole	2025-08-14
2025-06-30	$1,455,454	52,753	+362.7%	Shares	Sole	2025-08-14
2025-06-30	$1,418,126	51,400	-26.8%	Put	Sole	2025-08-14
2025-03-31	$2,557,170	90,200	+329.5%	Call	Sole	2025-05-15
2025-03-31	$323,190	11,400	-96.7%	Shares	Sole	2025-05-15
2025-03-31	$1,990,170	70,200	-17.4%	Put	Sole	2025-05-15
2024-12-31	$873,180	21,000	-81.8%	Call	Sole	2025-02-14
2024-12-31	$3,534,300	85,000	-93.6%	Put	Sole	2025-02-14
2024-09-30	$88,543,067	1,324,900	+347.6%	Put	Sole	2024-11-07
2024-09-30	$23,399,388	350,133	+549.6%	Shares	Sole	2024-11-07
2024-09-30	$7,718,865	115,500	-63.0%	Call	Sole	2024-11-07
2024-06-30	$6,400,743	53,901	+17.6%	Shares	Other	2024-08-14
2024-06-30	$35,150,000	296,000	+1380.0%	Put	Other	2024-08-14
2024-06-30	$37,061,875	312,100	+680.2%	Call	Other	2024-08-14
2024-03-31	$4,262,400	40,000	+300.0%	Call	Sole	2024-05-15
2024-03-31	$2,131,200	20,000	-77.8%	Put	Sole	2024-05-15
2023-12-31	$994,500	10,000	-71.4%	Call	Sole	2024-02-14
2023-12-31	$8,950,500	90,000	-38.6%	Put	Sole	2024-02-14
2023-09-30	$3,615,150	35,000	-97.0%	Call	Sole	2023-11-14
2023-09-30	$15,131,985	146,500	+14.4%	Put	Sole	2023-11-14
2023-06-30	$15,564,150	128,100	—	Put	Sole	2023-08-14
2023-03-31	$177,738,134	1,157,300	—	Call	Sole	2023-05-15
2022-06-30	$6,548,815	45,844	-40.7%	Shares	Sole	2022-08-15
2022-03-31	$13,316,214	77,303	+120.2%	Shares	Sole	2022-05-16
2021-03-31	$4,596,345	35,100	-68.4%	Shares	Sole	2021-05-17
2020-12-31	$11,606,199	111,096	-64.1%	Shares	Sole	2021-02-16
2020-09-30	$21,238,574	309,842	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.